drugs with tirzepatide | GLP1 | Medical Weight Loss FDA confirms tirzepatide shortage is

-Glu-C16, -L-glutamoyl(N -hexadecanoyl)

doi: 10.1007/s00384-014-2030-8 106 ZablockaBGoldspinkPHGoldspinkGGoreckiDC

Diary data showed a higher proportion of nopain days (89% vs 85%), and mean phototoxic reactions per patient were lower (2.03.3 vs 3.36.8)

This could include: Heart rate assessment at 4-8 weeks after initiation or dose escalation Periodic electrocardiography if arrhythmias are suspected Patient self-monitoring of pulse if symptomatic palpitations occur Evaluation of heart rate control in patients with atrial fibrillation When evaluating tachycardia in patients on GLP-1 therapy, clinicians should assess for other potential causes, including dehydration (especially from GI side effects), anemia, hyperthyroidism, stimulant use, infection, or other medications

see Vitamin B12 Health Professional Fact Sheet

Humira's most common side effects are reactions at the injection site